PMID- 23575666 OWN - NLM STAT- MEDLINE DCOM- 20131022 LR - 20211021 IS - 2041-1723 (Electronic) IS - 2041-1723 (Linking) VI - 4 DP - 2013 TI - FBXW7alpha attenuates inflammatory signalling by downregulating C/EBPdelta and its target gene Tlr4. PG - 1662 LID - 10.1038/ncomms2677 [doi] AB - Toll-like receptor 4 (Tlr4) has a pivotal role in innate immune responses, and the transcription factor CCAAT/enhancer binding protein delta (C/EBPdelta, Cebpd) is a Tlr4-induced gene. Here we identify a positive feedback loop in which C/EBPdelta activates Tlr4 gene expression in macrophages and tumour cells. In addition, we discovered a negative feedback loop whereby the tumour suppressor FBXW7alpha (FBW7, Cdc4), whose gene expression is inhibited by C/EBPdelta, targets C/EBPdelta for degradation when C/EBPdelta is phosphorylated by GSK-3beta. Consequently, FBXW7alpha suppresses Tlr4 expression and responses to the ligand lipopolysaccharide. FBXW7alpha depletion alone is sufficient to augment pro-inflammatory signalling in vivo. Moreover, as inflammatory pathways are known to modulate tumour biology, Cebpd null mammary tumours, which have reduced metastatic potential, show altered expression of inflammation-associated genes. Together, these findings reveal a role for C/EBPdelta upstream of Tlr4 signalling and uncover a function for FBXW7alpha as an attenuator of inflammatory signalling. FAU - Balamurugan, Kuppusamy AU - Balamurugan K AD - Laboratory of Cell and Developmental Signalling, National Cancer Institute-Frederick, PO Box B, Frederick, Maryland 21702-1201, USA. FAU - Sharan, Shikha AU - Sharan S FAU - Klarmann, Kimberly D AU - Klarmann KD FAU - Zhang, Youhong AU - Zhang Y FAU - Coppola, Vincenzo AU - Coppola V FAU - Summers, Glenn H AU - Summers GH FAU - Roger, Thierry AU - Roger T FAU - Morrison, Deborah K AU - Morrison DK FAU - Keller, Jonathan R AU - Keller JR FAU - Sterneck, Esta AU - Sterneck E LA - eng GR - HHSN261200800001C/RC/CCR NIH HHS/United States GR - HHSN261200800001E/CA/NCI NIH HHS/United States GR - ZIA BC010307-11/Intramural NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, N.I.H., Intramural PL - England TA - Nat Commun JT - Nature communications JID - 101528555 RN - 0 (Cebpd protein, mouse) RN - 0 (F-Box Proteins) RN - 0 (F-Box-WD Repeat-Containing Protein 7) RN - 0 (Fbxw7 protein, mouse) RN - 0 (Hif1a protein, mouse) RN - 0 (Hypoxia-Inducible Factor 1, alpha Subunit) RN - 0 (RNA, Messenger) RN - 0 (Tlr4 protein, mouse) RN - 0 (Toll-Like Receptor 4) RN - 142662-43-9 (CCAAT-Enhancer-Binding Protein-delta) RN - EC 2.3.2.27 (Ubiquitin-Protein Ligases) RN - EC 2.7.11.1 (GSK3B protein, human) RN - EC 2.7.11.1 (Glycogen Synthase Kinase 3 beta) RN - EC 2.7.11.1 (Gsk3b protein, mouse) RN - EC 2.7.11.26 (Glycogen Synthase Kinase 3) SB - IM MH - Animals MH - CCAAT-Enhancer-Binding Protein-delta/*physiology MH - Cell Line, Tumor MH - *Down-Regulation MH - F-Box Proteins/genetics/*physiology MH - F-Box-WD Repeat-Containing Protein 7 MH - Glycogen Synthase Kinase 3/metabolism MH - Glycogen Synthase Kinase 3 beta MH - Humans MH - Hypoxia-Inducible Factor 1, alpha Subunit/genetics MH - Inflammation/genetics/*physiopathology MH - Mice MH - RNA, Messenger/genetics MH - Signal Transduction/*physiology MH - Toll-Like Receptor 4/*physiology MH - Ubiquitin-Protein Ligases/genetics/*physiology PMC - PMC3625980 MID - NIHMS451081 EDAT- 2013/04/12 06:00 MHDA- 2013/10/23 06:00 PMCR- 2013/10/09 CRDT- 2013/04/12 06:00 PHST- 2012/09/28 00:00 [received] PHST- 2013/02/28 00:00 [accepted] PHST- 2013/04/12 06:00 [entrez] PHST- 2013/04/12 06:00 [pubmed] PHST- 2013/10/23 06:00 [medline] PHST- 2013/10/09 00:00 [pmc-release] AID - ncomms2677 [pii] AID - 10.1038/ncomms2677 [doi] PST - ppublish SO - Nat Commun. 2013;4:1662. doi: 10.1038/ncomms2677.